Grey Matters Health Inc. Advances US Alzheimer's Clinics
https://ow.ly/ZxY650Zgy0N
Grey Matters Health Inc. closes CA$1.25M financing to launch brain-specific PET clinics targeting the expanding Alzheimer's diagnostics market and early detection demand.
$GREY.CN $AGNPF
Alzheimer's Imaging Push Gains Fresh Funding as U.S. Clinic Plans Move Forward
https://ow.ly/LHub50ZglXR
Grey Matters Health Inc. ( $GREY.CN $AGNPF ) closed an expanded US$1.25 million private placement and said proceeds will support its Alzheimer's disease program and planned first U.S. brain-specific neuroimaging clinic.
Grey Matters Health Positions for Growth in Expanding Alzheimer's Diagnostics Market
https://ow.ly/In5w50Zaawh
Grey Matters Health advances its Alzheimer's neuroimaging strategy with fresh financing and plans for the first U.S. brain-specific PET clinic, capitalizing on rising demand for early detection tools.
$GREY.CN $AGNPF
Alzheimer's Diagnostic Clinic Initiative Moves Forward After Financing Close
https://ow.ly/wVZN50Z9H2r
Grey Matters Health Inc. ( $GREY.CN $AGNPF ) closed the first CA$500,000 tranche of a financing that the company said will support its Alzheimer's disease program and planned U.S. brain-specific neuroimaging clinic.
New Alzheimer's Imaging Push Expands as Financing Terms Get Investor-Friendly
https://ow.ly/mHpo50Z5I24
Grey Matters Health Inc. ( $GREY.CN $AGNPF ) amended warrant terms tied to its CA$1 million private placement as it advances plans for a U.S. brain-specific neuroimaging clinic focused on Alzheimer's diagnostics.
200 Brain PET Scans, 162 Alzheimer's Drugs: A Diagnostic Push Takes Shape
https://ow.ly/i5Hs50Z3gK4
Grey Matters Health Inc. ( $GREY.CN $AGNPF ) signed an LOI tied to a minimum of 200 brain PET scans for an Alzheimer's clinical trial while expanding its NovaScan neuroimaging strategy.
Name Change, Share Consolidation, and US Clinic Strategy Signal Shift Toward Alzheimer's Diagnostics
https://ow.ly/L2Zj50YEBwQ
Algernon Health ( $AGN.CN $AGNPF ) plans to rebrand to Grey Matters Health Inc. while advancing its Alzheimer's diagnostic strategy and U.S. clinic rollout.
First US Brain-Only PET Clinic Targets Alzheimer's Detection as Diagnostic Demand Expands
https://ow.ly/pgiM50YzTfi
Algernon Health ( $AGN.CN $AGNPF ) is opening its inaugural brain PET clinic in Florida with a five-year lease and renewal option.
America's First Brain-Dedicated PET Scanning Clinics: A Turnaround Play for Chart-Savvy Investors?
https://ow.ly/6g3h50YzjhR
Technical Analyst Stewart Thomson explains why he thinks Algernon Health ( $AGN.CN $AGNPF ) is a Strong Speculative Buy.
Healthcare Firm Targets Alzheimer's With Technology Breakthrough
https://ow.ly/pzjQ50WS8Fx
Healthcare company Algernon Health rebrands and unveils plan to open brain-specific PET scanning clinics in North America to meet rising demand for Alzheimer's diagnostics. Read more to learn how this shift positions the company at the center of a growing medical need.
$AGN.CN $AGNPF
Biotech Firm Adjusts Placement Terms to Fuel U.S. Expansion
https://ow.ly/owWk50Wm1Mz
Canadian healthcare and clinical stage drug development company Algernon Pharmaceuticals Inc. updates the pricing and warrant terms for its previously announced non-brokered private placement. Read why one technical analyst thinks the stock is ready to break out.
$AGN.CN $AGNPF
Biotech Firm Gains Exclusive Alzheimer's Rights in U.S. and Canada
https://ow.ly/qp4e50W1Ptk
Algernon Pharmaceuticals Inc. secures exclusive Alzheimer's clinic rights in Canada and key U.S. cities, positioning for a high-growth breakthrough. Learn how Algernon plans to launch cutting-edge clinics featuring PET scan technology and expand into a multibillion-dollar diagnostics market
$AGN.CN $AGNPF
Co. Poised to Begin Major New Bull Market: https://ow.ly/VjZB50VY19H
Technical Analyst Clive Maund explains why he thinks Algernon Pharmaceuticals Inc. is an Immediate Strong Buy.
$AGN.CN $AGNPF
